These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3172908)

  • 1. [Arterial hypertension secondary to Guillain-Barré syndrome. Treatment with a labetalol and chlorpromazine combination. Apropos of a case].
    Ayuso Gatell A; Martínez Ferrer JR; Trenchs Verdaguer X; Pujol Colomer J
    Med Clin (Barc); 1988 Jun; 91(3):105-7. PubMed ID: 3172908
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertension associated with the Guillain-Barré syndrome.
    Stapleton FB; Skoglund RR; Daggett RB
    Pediatrics; 1978 Oct; 62(4):588-90. PubMed ID: 714592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the the combination labetalol plus chlorthalidone in essential arterial hypertension therapy.
    Rossi AG
    Clin Ther; 1981; 3(6):441-9. PubMed ID: 7260990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of labetalol as a single treatment and labetalol combined with chlorthalidone in the treatment of severe arterial hypertension].
    Franco F; Colombo G; Salvioli G; Planca E
    Boll Chim Farm; 1988; 127(11-12):71S. PubMed ID: 3254253
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
    West MJ; Wing LM; Mulligan J; Walkley J; Grygiel JJ; Graham JR; Chalmers JP
    Med J Aust; 1980 Mar; 1(5):224-5. PubMed ID: 6990215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Labetalol and guanfacine in the treatment of arterial hypertension in patients with chronic renal failure].
    Lifshits NL; Ermolenko VM; Rozhdestvenskaia TM; Tatsievskiĭ VA; Panasiuk VV
    Ter Arkh; 1984; 56(7):66-9. PubMed ID: 6385325
    [No Abstract]   [Full Text] [Related]  

  • 7. Raised plasma renin activity in the hypertension of the Guillain-Barré syndrome.
    Laufer J; Passwell J; Keren G; Brandt N; Cohen BE
    Br Med J (Clin Res Ed); 1981 Apr; 282(6272):1272-3. PubMed ID: 6784811
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of labetalol and propranolol on the development of hypertension in spontaneously hypertensive rats.
    Gumułka WS; Zalewska-Rutczyńska Z
    Acta Physiol Pol; 1984; 35(1):41-6. PubMed ID: 6534080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined labetalol plus flunarizine treatment for arterial hypertension.
    Bonavita E
    Int J Clin Pharmacol Res; 1984; 4(6):475-80. PubMed ID: 6152439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of antihypertensive treatment with labetalol as compared with the combination of hydralazine and propranolol].
    Fea F; Salvioli G; Planca E; Pelliccioli I; Foti F; Colombo G
    Boll Soc Ital Cardiol; 1981; 26(12):2173-82. PubMed ID: 7185386
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular dysautonomia in Guillain Barre syndrome.
    Radhakrishnan K; Chopra JS; Khattri HN
    J Assoc Physicians India; 1982 Aug; 30(8):493-4. PubMed ID: 7169482
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypertensive crisis as the initial manifestation of Guillain-Barré-Landry syndrome].
    Campistol JM; Montoliu J; Blesa R; Torres A; Revert L
    Med Clin (Barc); 1987 Oct; 89(13):558-60. PubMed ID: 3695688
    [No Abstract]   [Full Text] [Related]  

  • 13. Dysautonomia in Guillain Barre syndrome.
    Bansal BC; Sood AK; Jain SK
    J Assoc Physicians India; 1987 Jun; 35(6):417-9. PubMed ID: 3654548
    [No Abstract]   [Full Text] [Related]  

  • 14. [The antihypertensive effectiveness of labetalol in combined therapy with diuretics].
    Colombo G; Fea F; Salvioli G; Planca E
    Boll Chim Farm; 1988; 127(11-12):67S-70S. PubMed ID: 3254252
    [No Abstract]   [Full Text] [Related]  

  • 15. [Guillain-Barré syndrome and extramembranous glomerulopathy. Apropos of a case].
    Dhib M; Moulin B; Godin M; Gourmelen O; Senant J; Le Loet X; Fillastre JP
    Ann Med Interne (Paris); 1989; 140(6):523-4. PubMed ID: 2696406
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of labetalol and propranolol in treatment of hypertension.
    Harvald B
    Postgrad Med J; 1980; 56 Suppl 2():65-8. PubMed ID: 7433346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysautonoemia and Guillain Barre syndrome.
    Sainani GS; Deshpande DV
    J Assoc Physicians India; 1982 Aug; 30(8):491-2. PubMed ID: 7169481
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in blood pressure in Guillain-Barre syndrome].
    Wang ML
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Apr; 21(2):95-6, 127. PubMed ID: 3208616
    [No Abstract]   [Full Text] [Related]  

  • 19. Labetalol: potent antihypertensive agent that blocks both alpha- and beta-adrenergic receptors.
    Milne BJ; Logan AG
    Can Med Assoc J; 1980 Nov; 123(10):1013-6. PubMed ID: 6256045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe hypertension: an unusual presentation of Guillain-Barré syndrome in a child with brucellosis.
    Al-Eissa YA; Al-Herbish AS
    Eur J Pediatr; 1996 Jan; 155(1):53-5. PubMed ID: 8750812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.